Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.

Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC, HARMONY-CTP study group.

Open source

DOI
10.1016/s1474-4422(16)30333-7
Published
2017-01-25
Container
Lancet Neurol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-16-30333-7,
  title = {Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.},
  author = {Szakacs Z and  Dauvilliers Y and  Mikhaylov V and  Poverennova I and  Krylov S and  Jankovic S and  Sonka K and  Lehert P and  Lecomte I and  Lecomte JM and  Schwartz JC and  HARMONY-CTP study group.},
  year = {2017},
  journal = {Lancet Neurol},
  doi = {10.1016/s1474-4422(16)30333-7},
  url = {https://doi.org/10.1016/s1474-4422(16)30333-7}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
AU  - Szakacs Z
AU  -  Dauvilliers Y
AU  -  Mikhaylov V
AU  -  Poverennova I
AU  -  Krylov S
AU  -  Jankovic S
AU  -  Sonka K
AU  -  Lehert P
AU  -  Lecomte I
AU  -  Lecomte JM
AU  -  Schwartz JC
AU  -  HARMONY-CTP study group.
PY  - 2017
JO  - Lancet Neurol
DO  - 10.1016/s1474-4422(16)30333-7
UR  - https://doi.org/10.1016/s1474-4422(16)30333-7
ER  - 

APA

Z, S., Y, D., V, M., I, P., S, K., S, J., K, S., P, L., I, L., JM, L., JC, S., & group., H. S. (2017). Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.. Lancet Neurol. https://doi.org/10.1016/s1474-4422(16)30333-7

Source records